These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 371663)

  • 81. Estradiol in premenstrual asthma: a double-blind, randomized, placebo-controlled, crossover study.
    Ensom MH; Chong G; Zhou D; Beaudin B; Shalansky S; Bai TR
    Pharmacotherapy; 2003 May; 23(5):561-71. PubMed ID: 12741429
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome.
    Baker ER; Best RG; Manfredi RL; Demers LM; Wolf GC
    J Assist Reprod Genet; 1995 Mar; 12(3):205-9. PubMed ID: 8520187
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Buspirone in treatment of premenstrual syndrome.
    Rickels K; Freeman E; Sondheimer S
    Lancet; 1989 Apr; 1(8641):777. PubMed ID: 2564578
    [No Abstract]   [Full Text] [Related]  

  • 84. Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study.
    Facchinetti F; Fioroni L; Sances G; Romano G; Nappi G; Genazzani AR
    Gynecol Obstet Invest; 1989; 28(4):205-8. PubMed ID: 2695413
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
    Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
    Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Oral magnesium successfully relieves premenstrual mood changes.
    Facchinetti F; Borella P; Sances G; Fioroni L; Nappi RE; Genazzani AR
    Obstet Gynecol; 1991 Aug; 78(2):177-81. PubMed ID: 2067759
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical trial of naltrexone in premenstrual syndrome.
    Chuong CJ; Coulam CB; Bergstralh EJ; O'Fallon WM; Steinmetz GI
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):332-6. PubMed ID: 3043289
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Spironolactone for the treatment of PMS.
    Hendler N
    Md Med J; 1992 Apr; 41(4):286. PubMed ID: 1569834
    [No Abstract]   [Full Text] [Related]  

  • 89. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms.
    Redei E; Freeman EW
    Psychoneuroendocrinology; 1995; 20(3):259-67. PubMed ID: 7777654
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea.
    Strömberg P; Akerlund M; Forsling ML; Granström E; Kindahl H
    Acta Obstet Gynecol Scand; 1984; 63(6):533-8. PubMed ID: 6542295
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Oral contraceptives containing drospirenone for premenstrual syndrome.
    Ma S; Song SJ
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD006586. PubMed ID: 37365881
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy of Treatments Targeting Hypothalamic-Pituitary-Adrenal Systems for Major Depressive Disorder: A Meta-Analysis.
    Ding Y; Wei Z; Yan H; Guo W
    Front Pharmacol; 2021; 12():732157. PubMed ID: 34566653
    [TBL] [Abstract][Full Text] [Related]  

  • 95. New Pharmacological Interventions in Bipolar Disorder.
    Juruena MF; Jelen LA; Young AH; Cleare AJ
    Curr Top Behav Neurosci; 2021; 48():303-324. PubMed ID: 33547595
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment.
    Kalkman HO
    Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32408603
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets.
    Hartlage SA; Freels S; Gotman N; Yonkers K
    Arch Gen Psychiatry; 2012 Mar; 69(3):300-5. PubMed ID: 22393222
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Premenstrual syndrome: approaches to diagnosis and treatment.
    Simkin RJ
    Can Fam Physician; 1985 Oct; 31():1959-67. PubMed ID: 21274209
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder.
    Breech LL; Braverman PK
    Int J Womens Health; 2010 Aug; 1():85-95. PubMed ID: 21072278
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Update on research and treatment of premenstrual dysphoric disorder.
    Cunningham J; Yonkers KA; O'Brien S; Eriksson E
    Harv Rev Psychiatry; 2009; 17(2):120-37. PubMed ID: 19373620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.